Drug intelligence / Profile preview

nitrated recombinant CCL2

Development stage
Preclinical
Lead developer
University of Texas Health Science Center at San Antonio
Modality
Recombinant Proteins and Enzymes
Administration
Intratumoral
01

Overview

Nitrated recombinant CCL2 is a post-translationally modified form of the chemokine C-C motif ligand 2 (CCL2) used in preclinical research to model tumor-induced immune evasion. In bladder cancer, the tumor microenvironment promotes the nitration of CCL2, which disrupts its normal function of recruiting tumor-protective CCR2+ T cells. Experimental nitration of recombinant CCL2 has been shown to abolish its therapeutic efficacy, leading instead to decreased T cell infiltration and increased recruitment of immunosuppressive monocytes. This modified protein serves as a critical tool for understanding how oxidative stress in the tumor microenvironment alters chemokine signaling and contributes to cancer progression.

Other names
nitrated rCCL2N-CCL2N-CCL-2N-CCL 2

Beyond the preview

Go deeper on nitrated recombinant CCL2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nitrated recombinant CCL2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call